SCHEMBL8465682

SCHEMBL8465682

COc1ccc2c(c1)C(=O)C(=Cc1ccccc1)CN2S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.51
▸ MIF P14174 1/20 0.49
▸ KCNN4 O15554 1/20 0.47
▸ KCNA3 P22001 1/20 0.47
▸ LMNA P02545 5/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ KMT2A Q03164 3/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ MAPT P10636 3/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ MMP2 P08253 1/20 0.43
▸ ACHE P22303 5/20 0.42
▸ BCHE P06276 2/20 0.42
▸ EGFR P00533 1/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29754934 0.88 KCNN4 (0.55) MAOBMIFKCNN4KCNA3LMNA
SCHEMBL28973132 0.88 KCNN4 (0.55) MAOBMIFKCNN4KCNA3LMNA
SCHEMBL28973111 0.85 KCNN4 (0.62) MAOBMIFKCNN4KCNA3LMNA
SCHEMBL29754844 0.85 KCNN4 (0.62) MAOBMIFKCNN4KCNA3LMNA
SCHEMBL8465676 0.81 LMNA (0.42) KCNN4KCNA3LMNAALDH1A1KDM4E
SCHEMBL8032658 0.80 LMNA (0.45) KCNN4KCNA3LMNAALDH1A1KDM4E
SCHEMBL30274382 0.79 MAPT (0.52) MIFLMNAALDH1A1KDM4EHPGD
SCHEMBL8465684 0.78 LMNA (0.43) KCNN4KCNA3LMNAALDH1A1KDM4E
SCHEMBL28973113 0.77 KCNN4 (0.57) MIFKCNN4KCNA3LMNAMMP2
SCHEMBL29754973 0.77 KCNN4 (0.57) MIFKCNN4KCNA3LMNAMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5998451-A LIPOXYGENASE INHIBITORS PFIZER INC (US) 1999-12-07 — — US disclosed
US-5059609-A Lipoxygenase inhibitors; leukotriene receptor blockers; psoriasis; antiulcer agents and myocardial infarctions PFIZER INC. (US) 1991-10-22 — — US disclosed
EP-0313295-A2 Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases PFIZER INC. (US) 1989-04-26 — — EP disclosed
Send feedback